Whitehawk Therapeutics (WHWK) Goodwill & Intangibles (2021 - 2022)
Whitehawk Therapeutics' (WHWK) quarterly Goodwill & Intangibles came in at $3.7 million in Q1 2022, down 1.78% on a QoQ basis from $3.8 million in Q4 2021.
Whitehawk Therapeutics (WHWK) Goodwill & Intangibles (2021 - 2022) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Goodwill & Intangibles data on file, last reported at $3.7 million in Q1 2022.
- On a quarterly basis, Goodwill & Intangibles changed N/A year-over-year to $3.7 million in Q1 2022; TTM through Mar 2022 was $3.7 million, a N/A change from a year earlier, with the FY2021 full-year figure at $3.8 million, changed N/A from the prior year.
- Goodwill & Intangibles for Q1 2022 stood at $3.7 million, down from $3.8 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for WHWK reached as high as $3.9 million in Q3 2021 and fell as low as $3.7 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 3.74 Mn |
| Dec 31, 2021 | 3.81 Mn |
| Sep 30, 2021 | 3.88 Mn |